Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.190
+0.180 (4.49%)
Aug 14, 2025, 2:32 PM - Market open
Aquestive Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 60.54 | 71.55 | 23.87 | 27.27 | 28.02 | 31.81 | Upgrade
|
| Cash & Short-Term Investments | 60.54 | 71.55 | 23.87 | 27.27 | 28.02 | 31.81 | Upgrade
|
| Cash Growth | -32.64% | 199.71% | -12.47% | -2.68% | -11.89% | -35.52% | Upgrade
|
| Accounts Receivable | 11.86 | 7.34 | 8.47 | 4.7 | 12.12 | 6.96 | Upgrade
|
| Receivables | 11.86 | 7.34 | 8.47 | 4.7 | 12.12 | 6.96 | Upgrade
|
| Inventory | 8.13 | 6.04 | 6.77 | 5.78 | 4.04 | 2.46 | Upgrade
|
| Prepaid Expenses | 1.2 | 3.29 | 1.85 | 2.13 | 3.08 | 3.4 | Upgrade
|
| Total Current Assets | 81.72 | 88.22 | 40.97 | 39.89 | 47.26 | 44.63 | Upgrade
|
| Property, Plant & Equipment | 8.77 | 8.98 | 9.74 | 9.3 | 7.78 | 10.32 | Upgrade
|
| Other Intangible Assets | - | - | 1.28 | 1.44 | 0.05 | 0.1 | Upgrade
|
| Other Long-Term Assets | 3.21 | 4.22 | 5.44 | 6.45 | 6.9 | 7.84 | Upgrade
|
| Total Assets | 93.7 | 101.42 | 57.42 | 57.07 | 61.99 | 62.88 | Upgrade
|
| Accounts Payable | 11.95 | 10.29 | 8.93 | 9.95 | 8.31 | 7.09 | Upgrade
|
| Accrued Expenses | 5.37 | 5.99 | 6.5 | 7.97 | 8.74 | 8.57 | Upgrade
|
| Current Portion of Long-Term Debt | 3.18 | 0.03 | 0.02 | 18.7 | 2.03 | 2.58 | Upgrade
|
| Current Portion of Leases | 0.57 | 0.51 | 0.39 | 0.26 | 0.9 | 0.73 | Upgrade
|
| Current Unearned Revenue | 2.09 | 2.05 | 2.47 | 2.66 | 1.99 | 2.14 | Upgrade
|
| Total Current Liabilities | 23.16 | 18.87 | 18.31 | 39.53 | 21.96 | 21.1 | Upgrade
|
| Long-Term Debt | 31.71 | 32.35 | 27.34 | 33.45 | 51.55 | 34.33 | Upgrade
|
| Long-Term Leases | 4.8 | 5.11 | 5.57 | 5.09 | 1.95 | 2.85 | Upgrade
|
| Long-Term Unearned Revenue | 81.86 | 82.72 | 95.91 | 95.53 | 66.18 | 51.16 | Upgrade
|
| Other Long-Term Liabilities | 24.76 | 22.52 | 16.78 | 2.03 | 2.49 | 1.95 | Upgrade
|
| Total Liabilities | 166.29 | 161.58 | 163.91 | 175.62 | 144.13 | 111.38 | Upgrade
|
| Common Stock | 0.1 | 0.09 | 0.07 | 0.06 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 327 | 302.97 | 212.52 | 192.6 | 174.62 | 137.73 | Upgrade
|
| Retained Earnings | -399.69 | -363.21 | -319.08 | -311.21 | -256.8 | -186.26 | Upgrade
|
| Total Common Equity | -72.59 | -60.16 | -106.49 | -118.55 | -82.13 | -48.5 | Upgrade
|
| Shareholders' Equity | -72.59 | -60.16 | -106.49 | -118.55 | -82.13 | -48.5 | Upgrade
|
| Total Liabilities & Equity | 93.7 | 101.42 | 57.42 | 57.07 | 61.99 | 62.88 | Upgrade
|
| Total Debt | 40.26 | 38 | 33.32 | 57.49 | 56.42 | 40.48 | Upgrade
|
| Net Cash (Debt) | 20.28 | 33.54 | -9.45 | -30.22 | -28.4 | -8.67 | Upgrade
|
| Net Cash Per Share | 0.22 | 0.39 | -0.15 | -0.62 | -0.75 | -0.26 | Upgrade
|
| Filing Date Shares Outstanding | 99.72 | 98.87 | 73.3 | 55.87 | 41.47 | 36.21 | Upgrade
|
| Total Common Shares Outstanding | 99.35 | 91.41 | 68.53 | 54.83 | 41.23 | 34.57 | Upgrade
|
| Working Capital | 58.57 | 69.36 | 22.66 | 0.36 | 25.3 | 23.52 | Upgrade
|
| Book Value Per Share | -0.73 | -0.66 | -1.55 | -2.16 | -1.99 | -1.40 | Upgrade
|
| Tangible Book Value | -72.59 | -60.16 | -107.77 | -119.99 | -82.19 | -48.6 | Upgrade
|
| Tangible Book Value Per Share | -0.73 | -0.66 | -1.57 | -2.19 | -1.99 | -1.41 | Upgrade
|
| Machinery | 23.98 | 23.77 | 23.64 | 23.21 | 22.49 | 25.54 | Upgrade
|
| Construction In Progress | 2.22 | 2.11 | 2.03 | 1.47 | 1.16 | 0.88 | Upgrade
|
| Leasehold Improvements | 21.42 | 21.42 | 21.39 | 21.38 | 21.27 | 21.33 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.